Imagem da capa

Pharmacogenomics

This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision s...

ver descrição completa

Na minha lista:
Formato: Online
Idioma:inglês
Publicado em: MDPI - Multidisciplinary Digital Publishing Institute 2022
Assuntos:
pharmacogenomics
return of results
genetic counseling
qualitative
pharmacogenetics
implementation
pharmacogenetics service
screening
pre-emptive
personalized medicine
precision medicine
community pharmacy
pharmacogenomic testing
genetic privacy
pharmaco-economics
polymorphisms
pharmacogenes
pharmacogenomic
machine learning
adaptation
human evolution
US Food and Drug Administration
clinical actionability
clinical translation
chronic kidney disease
CYP3A5
polymorphism
progression
pharmacogenomics (PGx)
pediatrics
best practice alerts (BPAs)
electronic health records (EHR)
genomic indicators
clinical decision support (CDS)
phenotype
genotype
polypharmacy
chronic disease
medication management
electronic medical record
artificial intelligence
n/a
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Acesso em linha:ONIX_20220506_9783036528359_133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Resumo:This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.

Registos relacionados